Vivozon, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2008-06-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.vivozon.com
Phase I Study to Investigate Safety, Tolerability, and Pharmacokinetics of VVZ-149 Injection
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: VVZ-149 InjectionDrug: placebo
- First Posted Date
- 2013-07-23
- Last Posted Date
- 2019-03-13
- Lead Sponsor
- Vivozon, Inc.
- Target Recruit Count
- 66
- Registration Number
- NCT01905410
- Locations
- 🇰🇷
Seoul National University Bundang Hospital, Sungnam-Si, Gyeonggi-Do, Korea, Republic of
© Copyright 2025. All Rights Reserved by MedPath